Cisapride for Intestinal Constipation (Q24234695)

2

0 references

Ramez Antakia

3

0 references

Umar Shariff

4

0 references

Richard L Nelson

Cochrane Database of Systematic Reviews

5

0 references

publication date

19 January 2011

0 references

published in

0 references

cites work

Cisapride for the treatment of constipation in children: A double-blind study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007780.PUB2

Cisapride therapy for gastrointestinal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007780.PUB2

Effects of oral cisapride on small bowel motility in irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007780.PUB2

Treatment of chronic constipation with cisapride and placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007780.PUB2

Use of cisapride in treatment of constipation in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007780.PUB2

Cisapride in neurologically impaired children with chronic constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007780.PUB2

Effects of cisapride on gall bladder emptying, intestinal transit, and serum deoxycholate: a prospective, randomised, double blind, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007780.PUB2

Role of serotonin in the pathophysiology of the irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007780.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007780.PUB2

A study of constipation in the elderly living at home

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007780.PUB2

Cisapride and ventricular arrhythmia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007780.PUB2

Epidemiology of constipation in North America: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007780.PUB2

Functional bowel disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007780.PUB2

Towards positive diagnosis of the irritable bowel

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007780.PUB2

Patients with constipation-predominant irritable bowel syndrome (IBS) may have elevated serotonin concentrations in colonic mucosa as compared with diarrhea-predominant patients and subjects with normal bowel habits

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007780.PUB2

Epidemiology of constipation in Europe and Oceania: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007780.PUB2

Bowel habits in young adults not seeking health care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007780.PUB2

Physician visits in the United States for constipation: 1958 to 1986.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007780.PUB2

The 5-HT(4) agonists cisapride, mosapride, and CJ-033466, a Novel potent compound, exhibit different human ether-a-go-go-related gene (hERG)-blocking activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007780.PUB2

The role of cisapride in the treatment of pediatric gastroesophageal reflux. The European Society of Paediatric Gastroenterology, Hepatology and Nutrition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007780.PUB2

Effect of cisapride on chronic idiopathic constipation in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007780.PUB2

Double-blind study of the effect of cisapride on constipation and abdominal discomfort as components of the irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007780.PUB2

7 January 2021

The symptomatic effect of cisapride in patients with irritable bowel syndrome and constipation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007780.PUB2

7 January 2021

Cisapride for children with intractable constipation: an interim verdict!

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007780.PUB2

7 January 2021

Treatment of intractable constipation in children: experience with cisapride

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007780.PUB2

7 January 2021

Cisapride in management of chronic pediatric constipation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007780.PUB2

7 January 2021

Review article: 5-hydroxytryptamine agonists and antagonists in the modulation of gastrointestinal motility and sensation: clinical implications

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007780.PUB2

7 January 2021

Cisapride in the treatment of gastro-oesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007780.PUB2

7 January 2021